Eugia US LLC recalls Lidocaine HCl Injection
- Recalling company
- Eugia US LLC
- Product
- Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
- Reason
- Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
- Classification
- Class III – not likely to cause adverse health consequences
- Recall date
- May 18, 2026
- Reported
- Jun 10, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 168,300 vials
- Lot / codes
- Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
- Company location
- East Windsor, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0552-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0552-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.